中国P站

Gut Microbiota; Intestinal Mucosal Barrier; Dysbiosis; Immune Response; Gastrointestinal Disorders; Probiotics; Prebiotics; Drug Metabolism; Gut-Brain Axis; Dietary Interventions

Introduction

The intricate relationship between the gut microbiota and overall health has become a focal point of scientific inquiry. Several studies highlight the multifaceted roles of gut bacteria in maintaining intestinal homeostasis and influencing various physiological processes. De Oliveira GLV, Maria RDL, and Irene ZC's work [1] underscores the significance of gut dysbiosis in Irritable Bowel Syndrome (IBS), emphasizing how imbalances in the microbial community can contribute to gastrointestinal disorders. Forrester CL, Kenji K, and Mark WM [2] delve into the mechanisms of microbiota-mucus interactions, revealing how bacteria actively shape the mucosal barrier to their advantage, promoting colonization and persistence. Renz H, Cathryn E, and Caitlin PB [3] examine the gut microbiota's role in influencing the development and function of the intestinal immune system, stressing the importance of early-life microbial exposure for shaping immune tolerance and preventing chronic inflammatory diseases. Hall AB, Mihail Y, and Julia S [4] focus on the interactions between the gut microbiota and the mucus layer in the context of Inflammatory Bowel Disease (IBD), identifying specific microbial signatures associated with disease severity and potential therapeutic targets. Mythili V, Naglaa S, and Ravi RS [5] review how the intestinal microbiota influences drug metabolism and bioavailability, discussing the potential for manipulating the microbiota to improve drug efficacy and reduce adverse effects. Rashim S, Hsi-Wen C, and Di Y [6] investigate the impact of dietary interventions on the gut microbiota and mucosal barrier function, demonstrating how specific dietary components can promote a healthy gut environment and prevent intestinal inflammation. Jessica LD, Evelien F, and Klaas W [7] explore the role of the gut microbiota in the pathogenesis of colorectal cancer, identifying specific microbial species that promote tumor growth and exploring potential strategies for targeting these bacteria to prevent or treat cancer. Julio P, Francisco JR, and Laura MV [8] discuss the potential of using probiotics and prebiotics to modulate the gut microbiota and improve mucosal barrier function, highlighting the importance of selecting the right strains and dosages for specific health conditions. Maria PF [9] investigates the impact of antibiotics on the gut microbiota and mucosal immunity, revealing how antibiotic exposure can disrupt the microbial balance and impair the host's ability to fight off infections. P S [10] explores the link between the gut microbiota and brain function, highlighting the role of microbial metabolites in modulating neural activity and behavior, discussing the implications of this gut-brain axis in neurological disorders.

Description

The gut microbiota, a complex community of microorganisms residing in the gastrointestinal tract, plays a pivotal role in human health[1]. Its influence extends beyond digestion, impacting immune function, metabolism, and even neurological processes. Dysbiosis, an imbalance in the gut microbial community, has been implicated in various gastrointestinal disorders, including Irritable Bowel Syndrome (IBS)[1] and Inflammatory Bowel Disease (IBD)[4]. Understanding the intricate interactions between the gut microbiota and the host is crucial for developing effective strategies to prevent and treat these conditions.

The mucosal barrier, a protective layer lining the intestinal tract, serves as the primary interface between the host and the gut microbiota. This barrier is composed of mucus, antimicrobial peptides, and immune cells, all working in concert to maintain intestinal homeostasis. Bacteria can actively shape the mucosal barrier to their advantage, promoting colonization and persistence[2]. Specific bacterial species can influence mucus production and glycosylation patterns, highlighting the dynamic interplay between the microbiota and the host's defense mechanisms.

Early-life microbial exposure is critical for shaping the development and function of the intestinal immune system[3]. The gut microbiota plays a crucial role in training the immune system to distinguish between harmless commensal bacteria and pathogenic invaders. Disruptions in this process can lead to immune dysregulation and an increased risk of chronic inflammatory diseases. Dietary interventions can modulate the gut microbiota and mucosal barrier function, promoting a healthy gut environment and preventing intestinal inflammation[6]. Specific dietary components can influence the composition and activity of the gut microbiota, impacting the host's immune response.

The gut microbiota also influences drug metabolism and bioavailability[5]. Microbial enzymes can modify drug molecules, altering their efficacy and toxicity. Manipulating the microbiota through probiotics, prebiotics, or dietary interventions holds promise for improving drug efficacy and reducing adverse effects. Furthermore, the gut microbiota has been linked to brain function, with microbial metabolites modulating neural activity and behavior[10]. This gut-brain axis opens up new avenues for understanding and treating neurological disorders. Targeting specific microbial species that promote tumor growth may offer novel strategies for preventing or treating cancer[7]. Antibiotics can disrupt the microbial balance and impair the host's ability to fight off infections[9]. Probiotics and synbiotics can modulate the gut microbiota and improve mucosal barrier function[8].

Conclusion

The gut microbiota plays a crucial role in human health, influencing immune function, metabolism, and neurological processes. Dysbiosis, or an imbalance in the gut microbial community, has been linked to gastrointestinal disorders like Irritable Bowel Syndrome and Inflammatory Bowel Disease. The mucosal barrier, composed of mucus, antimicrobial peptides, and immune cells, protects the intestinal tract. Bacteria can actively shape this barrier, influencing mucus production and glycosylation. Early-life microbial exposure is critical for shaping the intestinal immune system, with disruptions potentially leading to chronic inflammatory diseases. Dietary interventions can modulate the gut microbiota and mucosal barrier function, promoting gut health and preventing inflammation. Specific dietary components can impact the composition and activity of the microbiota, influencing the host's immune response. The gut microbiota also affects drug metabolism and bioavailability, with microbial enzymes modifying drug molecules. Manipulating the microbiota through probiotics, prebiotics, or dietary interventions shows promise for improving drug efficacy and reducing adverse effects. Furthermore, the gut-brain axis highlights the link between the gut microbiota and brain function, with microbial metabolites modulating neural activity and behavior, opening possibilities for treating neurological disorders. Targeting specific microbial species that promote tumor growth may offer strategies for cancer prevention or treatment. Antibiotics can disrupt microbial balance and impair the host's ability to fight infections, while probiotics and synbiotics can modulate the gut microbiota and improve mucosal barrier function.

References

1. Gabriela LVDO, Maria RDL, Irene ZC (2021) .Arch Immunol Ther 69:7.

   , ,

2. Catherine LF, Kenji K, Mark WM (2018) .Ann N Y Acad Sci 1417:33-45.

   , ,

3. Harald R, Cathryn E, Caitlin PB (2017) .Clin Exp Allergy 48:15-27.

   , ,

4. Audrey BH, Mihail Y, Julia S (2017) .Genome Med 9:103.

   , ,

5. Mythili V, Naglaa S, Ravi RS (2019) .Drug Metab Dispos 47:1317-1345.

   , ,

6. Rashim S, Hsi-Wen C, Di Y (2017) .J Transl Med 15:73.

   , ,

7. Jessica LD, Evelien F, Klaas W (2017) .Int J Mol Sci 18:686.

   , ,

8. Julio P, Francisco JR, Laura MV (2019) .Nutrients 11:29.

   , ,

9. Maria PF (2015) .Clin Microbiol Infect 21:S1-S8.

   , ,

10. P S (2018) .Brain Res 1693:128-133.

    , ,